Grafa News and Videos — Page 60

Riot Platforms (NASDAQ:RIOT) has fully repaid its $200 million Coinbase Credit facility.

Adicet Bio (NASDAQ:ACET) reported Phase 1 safety and efficacy data for prulacabtagene leucel (prula-cel) in patients with systemic lupus erythematosus with or without lupus nephritis.

BlossomHill Therapeutics (NASDAQ:BLSM) presented preclinical findings for BH-501284, an investigational pan-KRAS inhibitor, showing activity across KRAS-mutant cancer models.

Strategy Inc (NASDAQ:MSTR) bought 1,665 Bitcoin (BTC) for $142.7 million last week.

OSI Systems (NASDAQ:OSIS) received orders of approximately $7 million from a leading industrial controls original equipment manufacturer for electronic sub-assemblies.

Merck (NYSE:MRK) entered an exclusive global license agreement with SciBrunch Therapeutics for SPR2015, a preclinical oral KRAS G12D inhibitor being developed for potential cancer treatments.

SCYNEXIS (NASDAQ:SCYX) secured a contract with the Biomedical Advanced Research and Development Authority to support development of SCY-247, with potential funding of up to approximately $214 million.

The Securities and Futures Commission (SFC) and Accounting and Financial Reporting Council (AFRC) have signed a new regulatory cooperation agreement covering financial reporting and audits.

Valley National Bancorp (NASDAQ:VLY) agreed to acquire Bluevine for approximately $340 million in a cash-and-stock transaction expected to include about 75% cash and 25% Valley common stock.

Soluna Holdings (NASDAQ:SLNH) amended its agreement with Bitdeer Technologies Group (NASDAQ:BTDR) subsidiary Dory Creek to expand Bitcoin mining operations at Soluna’s Project Kati 1 in South Texas.